FdaApplication
ANDA 214856
Identifiers
- fda_app_no: ANDA214856
Properties
| Property | Value |
|---|---|
| applicant_name | EMERGE BIOSCIENCE PTE LTD |
| application_type | ANDA |
| approval_date | 2022-06-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENOXAPARIN SODIUM | ENOXAPARIN SODIUM | 300MG/3ML (100MG/ML) | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1 product